Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.

Khurana S, Norris PJ, Busch MP, Haynes BF, Park S, Sasono P, Mlisana K, Salim AK, Hecht FM, Mulenga J, Chomba E, Hunter E, Allen S, Nemo G, Rodriguez-Chavez IR; Women's Interagency HIV Study Collaborative Study Group, Margolick JB; Multicenter AIDS Cohort Study (MACS), Golding H.

J Clin Microbiol. 2010 Jan;48(1):281-5. doi: 10.1128/JCM.01573-09. Epub 2009 Nov 11.

2.

Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants.

Penezina O, Krueger NX, Rodriguez-Chavez IR, Busch MP, Hural J, Kim JH, O'Connell RJ, Hunter E, Aboud S, Higgins K, Kovalenko V, Clapham D, Crane D, Levin AE; HIV Selectest Study Group.

Clin Vaccine Immunol. 2014 Mar;21(3):391-8. doi: 10.1128/CVI.00748-13. Epub 2014 Jan 8.

3.

Assessment of sensitivity and specificity of first, second, and third generation EIA for the detection of antibodies to HIV-1 in oral fluid.

Louie B, Lei J, Liska S, Dowling T, Pandori MW.

J Virol Methods. 2009 Jul;159(1):119-21. doi: 10.1016/j.jviromet.2009.02.016. Epub 2009 Feb 24.

PMID:
19442855
4.

Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes.

Khurana S, Needham J, Park S, Mathieson B, Busch MP, Nemo G, Nyambi P, Zolla-Pazner S, Laal S, Mulenga J, Chomba E, Hunter E, Allen S, McIntyre J, Hewlett I, Lee S, Tang S, Cowan E, Beyrer C, Altfeld M, Yu XG, Tounkara A, Koita O, Kamali A, Nguyen N, Graham BS, Todd D, Mugenyi P, Anzala O, Sanders E, Ketter N, Fast P, Golding H.

J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):304-12.

5.

Identifying the early post-HIV antibody seroconversion period.

Hecht FM, Wellman R, Busch MP, Pilcher CD, Norris PJ, Margolick JB, Collier AC, Little SJ, Markowitz M, Routy JP, Holte S; Acute Infection Early Disease Research Program.

J Infect Dis. 2011 Aug 15;204(4):526-33. doi: 10.1093/infdis/jir304.

7.

Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.

Busch MP, Kleinman SH, Williams AE, Smith JW, Ownby HE, Laycock ME, Lee LL, Pau CP, Schreiber GB.

Transfusion. 1996 Jan;36(1):37-44.

PMID:
8607151
8.

Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays.

Weber B, Fall EH, Berger A, Doerr HW.

J Clin Microbiol. 1998 Aug;36(8):2235-9.

9.

Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein.

Wei X, Liu X, Dobbs T, Kuehl D, Nkengasong JN, Hu DJ, Parekh BS.

AIDS Res Hum Retroviruses. 2010 Jan;26(1):61-71. doi: 10.1089/aid.2009.0133.

PMID:
20063992
10.

Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.

Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS.

AIDS Res Hum Retroviruses. 2002 Mar 1;18(4):295-307.

PMID:
11860677
11.

Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions.

Apetrei C, Loussert-Ajaka I, Descamps D, Damond F, Saragosti S, Brun-Vézinet F, Simon F.

AIDS. 1996 Dec;10(14):F57-60.

PMID:
8970678
12.

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO.

AIDS. 2002 May 24;16(8):1119-29.

PMID:
12004270
13.

[A novel enzyme immunoassay system for the detection of HIV-1 p24 antigen with a sensitivity of 0.5 pg/ml].

Sharipova IN, Levina MA, Baranova EN, Obriadina AP, Burkov AN, Ulanova TI.

Klin Lab Diagn. 2008 Oct;(10):41-2. Russian.

PMID:
19069445
14.

Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion.

Soroka SD, Granade TC, Candal D, Parekh BS.

Clin Diagn Lab Immunol. 2005 Aug;12(8):918-21.

16.

The use of simple, rapid tests to detect antibodies to human immunodeficiency virus types 1 and 2 in pooled serum specimens.

Soroka SD, Granade TC, Phillips S, Parekh B.

J Clin Virol. 2003 May;27(1):90-6.

PMID:
12727534
17.

Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.

Khurana S, Needham J, Mathieson B, Rodriguez-Chavez IR, Catanzaro AT, Bailer RT, Kim J, Polonis V, Cooper DA, Guerin J, Peterson ML, Gurwith M, Nguyen N, Graham BS, Golding H.

J Virol. 2006 Mar;80(5):2092-9.

18.

Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.

Bentsen C, McLaughlin L, Mitchell E, Ferrera C, Liska S, Myers R, Peel S, Swenson P, Gadelle S, Shriver MK.

J Clin Virol. 2011 Dec;52 Suppl 1:S57-61. doi: 10.1016/j.jcv.2011.09.023. Epub 2011 Oct 12.

PMID:
21995929
20.

[The capacities of current test systems to verify early HIV infection].

Baranova EN, Sharipova IN, Denisova NM, Susekina ME, Puzyrev VF, Sarkisian KA, Vorob'eva MS, Burkov AN, Ulanova TI.

Vopr Virusol. 2009 Sep-Oct;54(5):37-40. Russian.

PMID:
19882902

Supplemental Content

Support Center